mental animals, whether these arise spontaneously, are produced by transplantation (including passage and hybridomas), or are induced by carcinogenic agents or genetic manipulation. They may be especially helpful in the completion of Project Licence Applications, in particular section 19b (v and vi) which requires that applicants list the possible adverse effects and their likely incidence as well as the proposed methods of controlling severity, e.g. the use of analgesia, regional or local anaesthesia and sedation, and the implementation of humane end points.
It is an important feature of the present guidelines that the procedures practised upon animals in cancer research, and particularly the humane end points used, should be subject to a continuous process of refinement. The guidelines will therefore be modified and updated as appropriate. The guidelines are not mandatory. The term 'should' is used to encourage attainment of desirable standards; the term 'must' is used only where legal obligations apply.
The Recommendations are divided into two parts. The General Recommendations are applicable to all regulated procedures. The Specific Recommendations are more directly targeted to the particular problems of experimental neoplasia. It is important to emphasize that procedural guidelines, especially with respect to implementation of humane end points, must be tailored to the precise nature of each individual experimental neoplasia model. To Where certain procedures cause particular concern, these must be noted specifically in the Project Licence application. A more detailed justification and definition of severity limits will be needed. Such procedures may be subject to additional conditions in the Personal Licence to control numbers of animals and/or severity. In addition, the Home Office may require particular reports on them. 4. It is important that pilot experiments should be undertaken on small numbers of animals before new procedures are carried out on a larger scale. The pilot experiments should identify particular problems, define the time scale of critical events, and help to refine the appropriate end point. In all experiments the numbers of animals used should be restricted to the minimum consistent with the design and purpose of the experiment. 5. All involved staff should be aware of their individual responsibilities and a clear chain of consultation should be established. The decision-making process should be designed so that under all circumstances appropriate action is taken promptly to deal with any problems which may arise, for example if the clinical condition of a tumour-bearing animal deteriorates unexpectedly or if the individual effects of tumour and therapeutic treatment are difficult to distinguish (see section 3.5). 6. All involved staff should receive appropriate training and supervision. Where research workers are using unfamiliar procedures, information and guidance should be obtained from experienced colleagues, as well as from the scientific literature.
Specific recommendations
1. Assessment of severity 1.1 Before assessing the severity of any regulated procedure on the well-being of an animal it is essential that the observer is familiar with the normally accepted behaviour, anatomy, physiology and environmental requirements of the species used, for example growth rate, dietary intake and microbial status. 1.2 Particular attention should be paid to those body systems most likely to be affected by the procedure. With solid tumours this will include ulceration, distension of covering tissues and cachexia. In the case of ascitic tumours, abdominal distension, anaemia and cachexia will be important. Lymphatic involvement from lymphoma and neurological disturbance from intracerebral tumours are examples of special complications arising in specific situations. 1.3 Certain deviations from normal well-being may be difficult to observe, for example induction of anaemia or the development of metastases, and special investigations may be required to detect them. Science, 235, 1622 Science, 235, , 1987 . Thus special care must be taken to ensure that such associated sequelae are identified and appropriate measures taken.
